Sissetulev kiriAvalik
Euroopa farmakopöa töökava asjus
Ravimiamet · 23. aprill 2026
- Viit
- REP-1/2345-1
- Registreeritud
- 23. aprill 2026
- Dokumendi liik
- Sissetulev kiri
- Adressaat
- European Directorate for the Quality of Medicines & HealthCare
- Saabumis/saatmisviis
- e-post
- Funktsioon
- REP Euroopa Farmakopöaga seotud asjaajamine
- Sari
- REP-1 Euroopa Farmakopöa alane kirjavahetus
- Toimik
- REP-1/2026
- Vastutaja
- Signe Leito (RA, Peadirektori asetäitja valdkond, Labor)
Sisu (failidest)
Signe Leito
Saatja: [email protected]
Saatmisaeg: reede, 17. aprill 2026 17:26
Adressaat: Signe Leito
Teema: Proposed addition of a new monograph to the Ph.Eur. work programme:
DANTROLENE: EDQM-2026-01987-mail
Järeltegevuse lipp: Järeltegevus
Olekulipp: Lipuga märgitud
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke
ja faile mitte avada.
Please make sure to include in any reply our mail reference: EDQM-2026-01987-mail
****************************************************************************
For the attention of NPAs
Copy: Presidium
Dear colleagues,
Please find below the link to a survey being carried out concerning the proposed addition
of DANTROLENE to the work programme of Group 10D:
https://survey.edqm.eu/index.php?r=survey/index&sid=227312&lang=en
Deadline for replies: 18 May 2026
With kind regards,
On behalf of Mathilde CAPDEROU,
Tiphaine STURTZ
Administrative assistant
European Pharmacopoeia Department (EPD)
EDQM - Council of Europe
https://www.edqm.eu
[email protected]
***************************************************************************
1
Please make sure to include in any reply our mail reference: EDQM-2026-01987-mail
2